NGLFINE.BO - NGL Fine-Chem Limited
NGL Fine-Chem Limited
301, E Square
Subhash Road Vile Parle (East)
Mumbai 400057
India
91 22 4084 2222
https://www.nglfinechem.com
Sector(s): Healthcare
Industry: Drug Manufacturers—General
Full Time Employees:
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Rahul Jayant Nachane | CEO, MD, Chief Ethics Counsellor & Exec. Director | 26.69M | N/A | 1964 |
| Mr. Rajesh Narayan Lawande | Whole Time Director & CFO | 26.55M | N/A | 1976 |
| Mr. Ahaan Nachane | VP | N/A | N/A | N/A |
| Ms. Pallavi Pednekar | Company Sec. & Compliance Officer | N/A | N/A | N/A |
Description
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, and marbofloxacin for animal health applications; and nitazoxanide, atovaquone, and ranolazine for human health applications. The company also provides various intermediate products; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Corporate Governance
NGL Fine-Chem Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
